Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins

Virology

Volumn 330, Issue 1, 2004, Pages 233-248

  Grundner, Christoph ^a   Pancera, Marie ^b   Kang, Joung Mo ^a   Koch, Markus ^a   Sodroski, Joseph ^a,c   Wyatt, Richard ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Envelope glycoproteins; HIV 1; Immunogenicity

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ARTICLE; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; T LYMPHOCYTE;

AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; DNA PRIMERS; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-4; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; RNA VIRUSES;

EID: 7544236606     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.08.037     Document Type: Article

References (56)

1. J. Alexander, J. Sidney, S. Southwood, J. Ruppert, C. Oseroff, A. Maewal, K. Snoke, H.M. Serra, R.T. Kubo, and A. Sette Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides Immunity 1 9 1994 751 761
2. T.W. Baba, V. Liska, R. Hofmann-Lehmann, J. Vlasak, W. Xu, S. Ayehunie, L.A. Cavacini, M.R. Posner, H. Katinger, G. Stiegler, B.J. Bernacky, T.A. Rizvi, R. Schmidt, L.R. Hill, M.E. Keeling, Y. Lu, J.E. Wright, T.C. Chou, and R.M. Ruprecht Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection Nat. Med. 6 2 2000 200 206
3. S.W. Barnett, S. Rajasekar, H. Legg, B. Doe, D.H. Fuller, J.R. Haynes, C.M. Walker, and K.S. Steimer Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit Vaccine 15 8 1997 869 873
4. S.W. Barnett, S. Lu, I. Srivastava, S. Cherpelis, A. Gettie, J. Blanchard, S. Wang, I. Mboudjeka, L. Leung, Y. Lian, A. Fong, C. Buckner, A. Ly, S. Hilt, J. Ulmer, C.T. Wild, J.R. Mascola, and L. Stamatatos The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region J. Virol. 75 12 2001 5526 5540
5. P.W. Berman, T.J. Gregory, L. Riddle, G.R. Nakamura, M.A. Champe, J.P. Porter, F.M. Wurm, R.D. Hershberg, E.K. Cobb, and J.W. Eichberg Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160 Nature 345 6276 1990 622 625
6. J.H. Brown, T.S. Jardetzky, J.C. Gorga, L.J. Stern, R.G. Urban, J.L. Strominger, and D.C. Wiley Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 Nature 364 6432 1993 33 39
7. C. Bruck, C. Thiriart, L. Fabry, M. Francotte, P. Pala, O. Van Opstal, J. Culp, M. Rosenberg, M. De Wilde, and P. Heidt HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees Vaccine 12 12 1994 1141 1148
8. S.L. Buge, H.L. Ma, R.R. Amara, L.S. Wyatt, P.L. Earl, F. Villinger, D.C. Montefiori, S.I. Staprans, Y. Xu, E. Carter, S.P. O'Neil, J.G. Herndon, E. Hill, B. Moss, H.L. Robinson, and J.M. McNicholl Gp120-alum boosting of a Gag-Pol-Env DNA/MVA AIDS vaccine: poorer control of a pathogenic viral challenge AIDS Res. Hum. Retroviruses 19 10 2003 891 900
9. R. Ceppellini, G. Frumento, G.B. Ferrara, R. Tosi, A. Chersi, and B. Pernis Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells Nature 339 6223 1989 392 394
10. A. Ciurea, L. Hunziker, M.M. Martinic, A. Oxenius, H. Hengartner, and R.M. Zinkernagel CD4+ T-cell-epitope escape mutant virus selected in vivo Nat. Med. 7 7 2001 795 800
11. M. Clerici, N.I. Stocks, R.A. Zajac, R.N. Boswell, D.C. Bernstein, D.L. Mann, G.M. Shearer, and J.A. Berzofsky Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals Nature 339 6223 1989 383 385
12. J.S. Culp, H. Johansen, B. Hellmig, J. Beck, T.J. Matthews, A. Delers, and M. Rosenberg Regulated expression allows high level production and secretion of HIV- 1 gp120 envelope glycoprotein in Drosophila Schneider cells Biotechnology (NY) 9 2 1991 173 177
13. G. Dai, N.K. Steede, and S.J. Landry Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120 J. Biol. Chem. 276 45 2001 41913 41920
14. A.G. Dalgleish, P.C. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus Nature 312 5996 1984 763 767
15. I. Dalum, M.R. Jensen, K. Gregorius, C.M. Thomasen, H.I. Elsner, and S. Mouritsen Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope Mol. Immunol. 34 16-17 1997 1113 1120
16. H. Deng, R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, C.B. Davis, S.C. Peiper, T.J. Schall, D.R. Littman, and N.R. Landau Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 6584 1996 661 666
17. D.C. Douek, J.M. Brenchley, M.R. Betts, D.R. Ambrozak, B.J. Hill, Y. Okamoto, J.P. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, Z. Grossman, M. Dybul, A. Oxenius, D.A. Price, M. Connors, and R.A. Koup HIV preferentially infects HIV-specific CD4+ T-cells Nature 417 6884 2002 95 98
18. P.L. Earl, B. Moss, and R.W. Doms Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein J. Virol. 65 4 1991 2047 2055
19. D.F. Hunt, H. Michel, T.A. Dickinson, J. Shabanowitz, A.L. Cox, K. Sakaguchi, E. Appella, H.M. Grey, and A. Sette Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad Science 256 5065 1992 1817 1820
20. P. Kolchinsky, E. Kiprilov, P. Bartley, R. Rubinstein, and J. Sodroski Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops J. Virol. 75 7 2001 3435 3443
21. B. Korber, F. Foley, C. Kuiken, S. Pillai, and J. Sodroski Numbering positions in HIV relative to HXBc2 J. Sodroski Human Retroviruses and AIDS 1998 Los Alamos National Laboratory Los Alamos, NM iii-102 iii-103
22. M. Kowalski, J. Potz, L. Basiripour, T. Dorfman, W.C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1 Science 237 4820 1987 1351 1355
23. P.D. Kwong, R. Wyatt, J. Robinson, R.W. Sweet, J. Sodroski, and W.A. Hendrickson Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody Nature 393 6686 1998 648 659
24. S.J. Lee, S. Evers, D. Roeder, A.F. Parlow, J. Risteli, L. Risteli, Y.C. Lee, T. Feizi, H. Langen, and M.C. Nussenzweig Mannose receptor-mediated regulation of serum glycoprotein homeostasis Science 295 5561 2002 1898 1901
25. H.X. Liao, G.J. Cianciolo, H.F. Staats, R.M. Scearce, D.M. Lapple, S.H. Stauffer, J.R. Thomasch, S.V. Pizzo, D.C. Montefiori, M. Hagen, J. Eldridge, and B.F. Haynes Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF Vaccine 20 17-18 2002 2396 2403
26. H.X. Liao, S.M. Alam, J.R. Mascola, J. Robinson, B. Ma, D.C. Montefiori, M. Rhein, L.L. Sutherland, R. Scearce, and B.F. Haynes Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins J. Virol. 78 10 2004 5270 5278
27. A.I. Ltd. HIV gp120 vaccine-VaxGen: AIDSVAX, AIDSVAX B/B, AIDSVAX B/E, HIV gp120 vaccine-Genentech, HIV gp120 vaccine AIDSVAX-VaxGen, HIV vaccine AIDSVAX-VaxGen Drugs R&D 4 4 2003 249 253
28. J.R. Mascola, S.W. Snyder, O.S. Weislow, S.M. Belay, R.B. Belshe, D.H. Schwartz, M.L. Clements, R. Dolin, B.S. Graham, G.J. Gorse, M.C. Keefer, M.J. McElrath, M.C. Walker, K.F. Wagner, J.G. McNeil, F.E. McCutchan, and D.S. Burke Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group J. Infect. Dis. 173 2 1996 340 348
29. J.R. Mascola, M.G. Lewis, G. Stiegler, D. Harris, T.C. VanCott, D. Hayes, M.K. Louder, C.R. Brown, C.V. Sapan, S.S. Frankel, Y. Lu, M.L. Robb, H. Katinger, and D.L. Birx Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies J. Virol. 73 5 1999 4009 4018
30. P.N. Nehete, W.C. Satterfield, C.M. Matherne, R.B. Arlinghaus, and K.J. Sastry Induction of human immunodeficiency virus-specific T-cell responses in rhesus monkeys by synthetic peptides from gp160 AIDS Res. Hum. Retroviruses 9 3 1993 235 240
31. P.N. Nehete, S.J. Schapiro, P.C. Johnson, K.K. Murthy, W.C. Satterfield, and K.J. Sastry A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans Viral Immunol. 11 3 1998 147 158
32. P. Panina-Bordignon, A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia Universally immunogenic T-cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T-cells Eur. J. Immunol. 19 12 1989 2237 2242
33. R. Pantophlet, I.A. Wilson, and D.R. Burton Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design J. Virol. 77 10 2003 5889 5901
34. P.W. Parren, D.R. Burton, and Q.J. Sattentau HIV-1 antibody-Debris or virion? Nat. Med. 3 4 1997 366 367
35. P.W. Parren, P.A. Marx, A.J. Hessell, A. Luckay, J. Harouse, C. Cheng-Mayer, J.P. Moore, and D.R. Burton Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro J. Virol. 75 17 2001 8340 8347
36. C. Rizzuto, and J. Sodroski Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120 AIDS Res. Hum. Retroviruses 16 8 2000 741 749
37. C.D. Rizzuto, R. Wyatt, N. Hernandez-Ramos, Y. Sun, P.D. Kwong, W.A. Hendrickson, and J. Sodroski A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding Science 280 5371 1998 1949 1953
38. E.S. Rosenberg, J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams, and B.D. Walker Vigorous HIV-1-specific CD4+ T-cell responses associated with control of viremia Science 278 5342 1997 1447 1450
39. A. Rudensky, P. Preston-Hurlburt, S.C. Hong, A. Barlow, and C.A. Janeway Jr. Sequence analysis of peptides bound to MHC class II molecules Nature 353 6345 1991 622 627
40. A. Rudensky, P. Preston-Hurlburt, B.K. al-Ramadi, J. Rothbard, and C.A. Janeway Jr. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs Nature 359 6394 1992 429 431
41. R.W. Sanders, M. Venturi, L. Schiffner, R. Kalyanaraman, H. Katinger, K.O. Lloyd, P.D. Kwong, and J.P. Moore The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120 J. Virol. 76 14 2002 7293 7305
42. S. Sarkar, V. Kalia, M. Murphey-Corb, and R.C. Montelaro Characterization of CD4+ T helper cell fine specificity to the envelope glycoproteins of simian immunodeficiency virus J. Med. Primatol. 31 4-5 2002 194 204
43. S. Sarkar, V. Kalia, M. Murphey-Corb, and R.C. Montelaro Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope J. Immunol. 168 8 2002 4001 4011
44. C.N. Scanlan, R. Pantophlet, M.R. Wormald, E. Ollmann Saphire, R. Stanfield, I.A. Wilson, H. Katinger, R.A. Dwek, P.M. Rudd, and D.R. Burton The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1->2 mannose residues on the outer face of gp120 J. Virol. 76 14 2002 7306 7321
45. F. Sinigaglia, M. Guttinger, J. Kilgus, D.M. Doran, H. Matile, H. Etlinger, A. Trzeciak, D. Gillessen, and J.R. Pink A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules Nature 336 6201 1988 778 780
46. K.V. Sitz, S. Ratto-Kim, A.S. Hodgkins, M.L. Robb, and D.L. Birx Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controls J. Infect. Dis. 179 4 1999 817 824
47. B.R. Starcich, B.H. Hahn, G.M. Shaw, P.D. McNeely, S. Modrow, H. Wolf, E.S. Parks, W.P. Parks, S.F. Josephs, and R.C. Gallo Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS Cell 45 5 1986 637 648
48. S. Surman, T.D. Lockey, K.S. Slobod, B. Jones, J.M. Riberdy, S.W. White, P.C. Doherty, and J.L. Hurwitz Localization of CD4+ T-cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing Proc. Natl. Acad. Sci. U. S. A. 98 8 2001 4587 4592
49. A. Trkola, M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J.P. Moore, and H. Katinger Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 J. Virol. 70 2 1996 1100 1108
50. T.C. VanCott, J.R. Mascola, L.D. Loomis-Price, F. Sinangil, N. Zitomersky, J. McNeil, M.L. Robb, D.L. Birx, and S. Barnett Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope J. Virol. 73 6 1999 4640 4650
51. B. Wahren, J. Rosen, E. Sandstrom, T. Mathiesen, S. Modrow, and H. Wigzell HIV-1 peptides induce a proliferative response in lymphocytes from infected persons J. Acquired Immune Defic. Syndr. 2 5 1989 448 456
52. L. Wu, N.P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A.A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 Nature 384 6605 1996 179 183
53. R. Wyatt, and J. Sodroski The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens Science 280 5371 1998 1884 1888
54. R. Wyatt, N. Sullivan, M. Thali, H. Repke, D. Ho, J. Robinson, M. Posner, and J. Sodroski Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions J. Virol. 67 8 1993 4557 4565
55. R. Wyatt, J. Moore, M. Accola, E. Desjardin, J. Robinson, and J. Sodroski Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding J. Virol. 69 9 1995 5723 5733
56. X. Zhan, K.S. Slobod, S. Surman, S.A. Brown, T.D. Lockey, C. Coleclough, P.C. Doherty, and J.L. Hurwitz Limited breadth of a T-helper cell response to a human immunodeficiency virus envelope protein J. Virol. 77 7 2003 4231 4236